Skip to main content
OpenTrials

Clinical trial condition

Endocrine Gland Neoplasms

Explore clinical trials studying Endocrine Gland Neoplasms. Study availability and eligibility vary by location and protocol.

6,112 public trials 1,370 recruiting studies
Refine in advanced search Browse all conditions

Endocrine Gland Neoplasms trial results

Completed

RRx-001 in Lung Cancer, Ovarian Cancer and Neuroendocrine Tumors Prior to Re-administration of Platinum Based Doublet Regimens (QUADRUPLE THREAT)

NCT02489903

Conditions
Adnexal Diseases, Bronchial Neoplasms, Carcinoma, +31 more
Locations
  • Stanford University Palo Alto, California, United States
  • VA Connecticut Cancer Center West Haven, Connecticut, United States
  • Memorial Hospital of South Bend South Bend, Indiana, United States
  • Baptist Health Lexington, Kentucky, United States
View Trial Details
Completed

p53 Suppressor Activation in Recurrent High Grade Serous Ovarian Cancer, a Phase Ib/II Study of Systemic Carboplatin Combination Chemotherapy With or Without APR-246

NCT02098343

Conditions
Adnexal Diseases, Disease Attributes, Endocrine Gland Neoplasms, +17 more
Locations
  • UCLA Los Angeles, California, United States
  • University of Chicago Chicago, Illinois, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View all 55 locations
View Trial Details
Completed

HPV Vaccine Intervention for Young Sexual Minority Men

NCT04032106

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine Gland Neoplasms, Endocrine System Diseases, +8 more
Locations
  • University of Minnesota Minneapolis, Minnesota, United States
  • Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
View Trial Details
Completed

Clinical Trial Comparing Gemcitabine and Vandetanib Therapy With Gemcitabine Alone in Pancreatic Carcinoma

NCT01601808

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations
  • Belfast City Hospital Belfast, United Kingdom
  • The Royal Bournemouth Hospital Bournemouth, United Kingdom
  • Bristol Haematology and Oncology Centre Bristol, United Kingdom
  • Royal Surrey County Hospital Guildford, United Kingdom
View all 14 locations
View Trial Details
Completed

Atezolizumab, Guadecitabine, and CDX-1401 Vaccine in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

NCT03206047

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +20 more
Locations
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
  • University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
View all 17 locations
View Trial Details

Related conditions